The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Bionano Genomics, Inc(NASDAQ:BNGO) 
Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the sear...
Website: http://www.bionanogenomics.com
Founded: 2003
Full Time Employees: 97
CEO: Erik Holmlin
Sector: Healthcare
Industry: Diagnostics & Research
Bionano Genomics Number of Twitter Followers
Bionano Genomics Days Payable Outstanding ttm (DPO)
Bionano Genomics Days Receivable Outstanding ttm (DSO)
Bionano Genomics Days Inventory Outstanding ttm (DIO)
Bionano Genomics Op Cashflow Per Share ttm
Bionano Genomics Free Cashflow Per Share ttm
Bionano Genomics Cash Per Share ttm
Bionano Genomics P/S ratio ttm
Bionano Genomics (GAAP) P/E ratio ttm
Bionano Genomics P/B ratio ttm
No extra charts and metrics for this ticker.